Unusual four-stranded genetic structures have been detected directly in human blood plasma, suggesting that our DNA may carry information not only through its sequence but also through its physical shape. The finding could eventually transform how doctors analyze blood for signs of disease.
Most people picture DNA as the familiar double helix, yet genetic material can also fold into more complex configurations. One such structure, known as a G-quadruplex or G4, consists of four DNA or RNA strands arranged into compact stacks.
What are G-quadruplex structures?
G-quadruplexes form when segments rich in the genetic letter guanine create square-like units that stack together into a stable, four-stranded structure. These configurations differ dramatically from the linear, ladder-like double helix commonly shown in textbooks.
Inside cells, G4s commonly appear near gene-control regions and chromosome ends, where they are thought to influence gene activity and genome stability. Previous studies had detected G4 structures within cells, but their presence in blood plasma had not been clearly demonstrated.
Detecting folded DNA in plasma
The new research focuses on cell-free DNA, tiny genetic fragments released into the bloodstream as cells die and break apart. These fragments are already used in prenatal screening and cancer diagnostics to detect genetic mutations and epigenetic patterns.
Researchers had previously identified extremely short fragments, approximately 50 bases long, that were rich in guanine and theoretically capable of forming G4 structures. However, demonstrating that these fragments were actually folded in blood rather than forming during laboratory processing presented a major technical challenge.
Standard DNA extraction procedures often involve heating and harsh chemicals that can destroy delicate molecular structures or allow new ones to form during processing. To overcome this problem, the researchers developed a gentler protocol that captured nucleic acids directly from plasma while preserving their natural shape.
The team then used two independent detection methods: a specialized antibody that binds to G4 structures and a small-molecule dye that glows when attached to G4s. Both methods produced strong signals, while control sequences incapable of folding into G4 structures showed no response.
Unanswered questions and next steps
The detection tools recognize the folded architecture itself rather than determining whether it is composed of DNA or RNA. As a result, the study cannot yet establish which type of molecule carries these G4 structures in plasma, a limitation acknowledged by the authors.
Future experiments will involve treating samples with enzymes that selectively degrade either DNA or RNA before analysis. Comparing the resulting signals should help reveal the chemical identity of the folded fragments and eventually allow researchers to sequence their genomic origins.
Scientists also hope to determine which tissues release these structures and whether the G4s form inside cells before being released or fold only after entering the bloodstream. Answering these questions will be important for understanding their biological role.
Potential implications for cancer and beyond
Elevated levels of G-quadruplex structures have been reported in several tumor types, while a number of cancer drugs in development target G4s in an effort to disrupt tumor cell proliferation. Circulating G4 structures could therefore carry distinctive information about malignant activity.
If specific patterns of G4s eventually emerge in the blood of patients with particular cancers, they could complement existing liquid biopsy tests. Current approaches primarily examine sequence changes, fragment size and methylation signals in cell-free DNA.
The authors emphasize that the study represents a proof of principle rather than a diagnostic breakthrough. The researchers did not compare patients with cancer against healthy volunteers, meaning any potential clinical application remains speculative and is likely years away.
For now, the findings highlight that genetic material circulating in the bloodstream may represent more than a simple string of genetic letters. Its three-dimensional folding could provide an additional layer of biological information that conventional sequencing methods cannot detect.
As analytical techniques improve, scientists expect further discoveries about how nucleic acid structures circulate through blood and other body fluids. Such insights could eventually reshape how clinicians monitor disease, follow treatment responses and investigate the hidden dynamics of the human genome.
